17 Capital Partners’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
27,717
+3,012
+12% +$179K 0.78% 31
2026
Q1
$1.24M Buy
24,705
+2,346
+10% +$125K 0.64% 41
2025
Q4
$1.23M Buy
22,359
+6,575
+42% +$357K 0.63% 49
2025
Q3
$847K Buy
15,784
+1,751
+12% +$89.2K 0.46% 79
2025
Q2
$677K Buy
14,033
+2,487
+22% +$106K 0.39% 86
2025
Q1
$461K Buy
11,546
+526
+5% +$23.8K 0.3% 103
2024
Q4
$510K Buy
11,020
+913
+9% +$41.4K 0.32% 92
2024
Q3
$432K Buy
10,107
+2,295
+29% +$94.9K 0.28% 97
2024
Q2
$332K Buy
7,812
+1,868
+31% +$73.8K 0.24% 104
2024
Q1
$229K Buy
+5,944
New +$214K 0.17% 115

Other funds holding FBCG

17 Capital Partners's FBCG Position: Q2 2026 in Review

17 Capital Partners increased its Fidelity Blue Chip Growth ETF (FBCG) stake by 12% in Q2 2026, buying an estimated $179K and bringing the position to 27,717 shares worth $1.72M. The position accounts for 0.78% of the portfolio, ranked #31.

17 Capital Partners first reported a position in FBCG in Q1 2024 and has held it in 10 quarters since. 317 funds tracked by Wall St. Rank hold FBCG as of Q2 2026.

  • 17 Capital Partners held 27,717 shares of Fidelity Blue Chip Growth ETF worth $1.72M as of Q2 2026.
  • 17 Capital Partners bought 3,012 Fidelity Blue Chip Growth ETF shares in Q2 2026, an estimated $179K.
  • Fidelity Blue Chip Growth ETF made up 0.78% of 17 Capital Partners's portfolio in Q2 2026, its #31 holding.
  • 17 Capital Partners first reported a position in Fidelity Blue Chip Growth ETF in Q1 2024 and has held it in 10 quarters since.
  • 317 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q2 2026.

Based on 17 Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.